Cybin (HELP) Free Cash Flow (2020 - 2026)
Cybin (HELP) posted quarterly Free Cash Flow of -$37.3 million for Q1 2026, down 153.44% year-on-year from $69.8 million in Q1 2025, and down 18.14% on a QoQ basis from -$31.6 million in Q4 2025.
Cybin (HELP) Free Cash Flow (2020 - 2026) Analysis & Trends
Cybin (HELP) has reported Free Cash Flow for 7 consecutive years, with -$37.3 million the latest figure, recorded in Q1 2026.
- Quarterly Free Cash Flow fell 153.44% year-over-year to -$37.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$132.2 million (down 81.72% YoY) and the FY2026 annual result came in at -$133.3 million, down 82.89% from the prior year.
- Free Cash Flow eased to -$37.3 million in Q1 2026 per HELP's latest filing, from -$31.6 million in the prior quarter.
- Over the last five years, Free Cash Flow for HELP reached as high as $5.0 million in Q2 2022 and fell as low as -$37.3 million in Q1 2026.
- A 5-year average of -$15.9 million and a median of -$15.7 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow soared 32.77% — and 2026, when it tumbled 153.44%.
- Year by year, Free Cash Flow stood at -$7.9 million in 2022, then slumped by 139.48% to -$19.0 million in 2023, then decreased by 1.04% to -$19.2 million in 2024, then sank by 64.4% to -$31.6 million in 2025, then dropped by 18.14% to -$37.3 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$37.3 million, -$31.6 million, and -$34.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | -37.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.29 Mn |
| Mar 31, 2026 | -37.29 Mn |
| Dec 31, 2025 | -31.56 Mn |
| Dec 31, 2025 | -31.56 Mn |
| Sep 30, 2025 | -34.05 Mn |
| Sep 30, 2025 | -34.05 Mn |
| Jun 30, 2025 | -29.32 Mn |
| Jun 30, 2025 | -29.32 Mn |
| Mar 31, 2025 | -14.71 Mn |
| Mar 31, 2025 | -14.71 Mn |
| Dec 31, 2024 | -19.20 Mn |
| Dec 31, 2024 | -19.20 Mn |
| Sep 30, 2024 | -18.95 Mn |
| Sep 30, 2024 | -18.95 Mn |
| Jun 30, 2024 | -19.90 Mn |
| Jun 30, 2024 | -19.90 Mn |
| Mar 31, 2024 | -15.75 Mn |
| Mar 31, 2024 | -15.75 Mn |
| Dec 31, 2023 | -19.00 Mn |
| Dec 31, 2023 | -19.00 Mn |